13,823 results match your criteria: "Thyroid Nodule"
Ann Med Surg (Lond)
December 2024
Department of Urology, School of Medicine, Ibb University, Ibb, Yemen.
Background: Accurately diagnosing thyroid nodules is vital for preventing unnecessary surgeries and providing prompt therapy. Although fine-needle aspiration cytology (FNAC) and ultrasonography (US) are widely used diagnostic methods, their reliability is questioned. This study investigates the effectiveness of US and FNAC in thyroid nodule diagnosis and differentiates benign from malignant nodules in relation to final histopathological diagnosis.
View Article and Find Full Text PDFEndocr Pract
December 2024
Section of Endocrine Surgery, Department of Surgery, David Geffen School of Medicine, University of California Los Angeles.
Semergen
December 2024
Medicina Familiar y Comunitaria, Centro de Salud Don Benito Oeste, Don Benito, Badajoz; Miembro del Grupo de Trabajo de Ecografía de SEMERGEN, España.
The thyroid nodule is a frequent lesion within the thyroid. Its incidence is between 50%-60% and most of them are asymptomatic and benign (90-95%) and its diagnosis is frequently made as an incidental finding. The main objective of their study is to rule out thyroid cancer.
View Article and Find Full Text PDFData Brief
December 2024
Universidad Nacional de Asunción, Facultad Politécnica, San Lorenzo 111421, Paraguay.
This article presents a dataset containing 641 images of Thyroid Gammagraphies studies corresponding to 235 patients over 18 years of age that were acquired in the period from 2016 to 2024 at the Nuclear Medicine Service of the of the (IICS - UNA), Paraguay. First, the Thyroid Gammagraphies images were acquired according to the acquisition protocol described in this article. The thyroid scintigraphies images were acquired using trimodal SPECT-CT-PET equipment, model AnyScan SCP, MEDISO brand.
View Article and Find Full Text PDFFront Endocrinol (Lausanne)
December 2024
Department of Pediatrics, Endocrinology, Diabetology with Cardiology Divisions, Medical University of Bialystok, Bialystok, Poland.
J Med Case Rep
December 2024
Faculty of Medicine of Tunis, Tunis El Manar University, 1007, Tunis, Tunisia.
Rev Assoc Med Bras (1992)
December 2024
Gaziantep University, School of Medicine, Department of Endocrinology and Metabolism - Gaziantep, Turkey.
Thyroid
December 2024
Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
Afirma Genomic Sequencing Classifier (GSC) testing has been utilized for further risk stratification of thyroid nodules categorized as atypia of undetermined significance (AUS). The 2023 Bethesda system subcategorizes AUS diagnosis into AUS with nuclear atypia (AUS-N) and other atypia (AUS-O). The current study aims to determine if performance of GSC testing differs between the two AUS subcategories and between single AUS cohort and repeat AUS cohort.
View Article and Find Full Text PDFJ Endocrinol Invest
December 2024
Endocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy.
Purpose: Thyroid nodules diagnosed by fine needle aspiration cytology (FNAC) as TIR3A or Class III subgroup "other types of atypia" (indeterminate thyroid nodules - ITNs), are the only ones without a unique clinical action indicated for management. This leads to multiple FNAC repetitions (FNAC-reps) and lifelong follow-up, with huge consumption of time and resources. The aims of the study were to inquire the usefulness of repeating FNAC in ITNs and perform an evaluation of a long-term follow-up of a large cohort of ITNs.
View Article and Find Full Text PDFClin Radiol
November 2024
Department of Radiology, Queen Alexandra Hospital, Portsmouth, UK.
Front Endocrinol (Lausanne)
December 2024
Department of Ultrasound, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, China.
Cureus
November 2024
Radiology, Dubai Health Authority, Dubai, ARE.
Zhonghua Zhong Liu Za Zhi
November 2024
Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing100021, China.
Biomed Environ Sci
October 2024
The Department of Endemic Diseases, Fujian Center for Disease Control and Prevention Fujian, Fuzhou 350012, Fujian, China.
Front Endocrinol (Lausanne)
November 2024
Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Front Endocrinol (Lausanne)
December 2024
Department of Pediatric Surgery, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Cureus
October 2024
Department of Pathology and Forensic Medicine, Faculty of Medicine, Ivane Javakhishvili Tbilisi State University, Tbilisi, GEO.
Clin Radiol
November 2024
Imperial College Healthcare NHS Trust, UK. Electronic address:
Int J Surg Case Rep
November 2024
Department of oncology, Royal medical services, Jordan.
Sci Rep
November 2024
Department of Ultrasonic, Shanxi Provincial People's Hospital, 29 shuangtaisi street, yingze district, Taiyuan, Shanxi, 030001, China.
Endocrine
November 2024
Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Purpose: To investigate the efficacy of ultrasound (US)-guided percutaneous MWA for benign thyroid nodules with cosmetic problems and identify related factors contributing to post-ablative complete relief (CR).
Methods: This retrospective study reviewed the efficacy of MWA in treating thyroid nodules in patients with cosmetic problems who underwent MWA from January 2021 to May 2023. Patients were followed up at 1, 3, and 6 months after MWA.
Front Oncol
November 2024
Center for Clinical Genetics and Genomics, Dian Diagnostics Group Co., Ltd., Hangzhou, China.
Background: Fine-needle aspiration (FNA) biopsy is typically used in conjunction with cytopathologic evaluation to differentiate between benign and malignant thyroid nodules. Even so, the cytology results for 20-30% of thyroid nodules are indeterminate. This study sought to evaluate the usefulness of next-generation sequencing (NGS)-based multi-gene panel testing for risk stratification and the differentiation of benign from malignant thyroid nodules.
View Article and Find Full Text PDFClin Imaging
January 2025
Yeditepe University Hospitals, Department of Radiology, Kosuyolu 34718, Istanbul, Turkey. Electronic address:
Purpose: To compare the diagnostic performance of six different currently available guidelines including the American College of Radiology Thyroid Imaging and Reporting Data System (ACR-TIRADS), Kwak-TIRADS, Korean TIRADS (K-TIRADS), European TIRADS (EU-TIRADS), American Thyroid Association (ATA) and Chinese TIRADS (C-TIRADS), in differentiating malignant from benign thyroid nodules (TN).
Materials And Methods: In this single-center study, between January-2007 and September-2023, ultrasound (US) images of TNs that were pathologically proven either by surgery or by fine needle aspiration biopsy (FNAB), were retrospectively evaluated and categorized according to six different currently available guidelines. Area under curve (AUC), sensitivity, specificity, positive and negative predictive values (PPV and NPV, respectively) and miss rates for malignancy (MRM) were calculated for each guideline.
Jpn J Radiol
November 2024
MRI Unit, Radiology Department, HT Médica, Carmelo Torres 2, 23007, Jaén, Spain.
Objective: The ACR Thyroid Imaging, Reporting, and Data System (TI-RADS) uses a score based on ultrasound (US) imaging to stratify the risk of nodule malignancy and recommend appropriate follow-up. This study aims to analyze US reports and explore how Natural Language Processing (NLP) leveraging Transformers models can classify ACR TI-RADS from text reports using the description of thyroid nodule features.
Materials And Methods: This retrospective study evaluated 16,847 thyroid-free text reports from our institution.